PHARMANEST grants free right of access to use, copy, distribute the contents of it in any manner.
PHARMANEST is an International peer reviewed Journal aimed to provide platform for exchange of ideas that emerge out of the research work carried out either in academics or at industry. The language of Journal is English, and articles will be accepted from any country provided that they are submitted in English language only. The articles should provide consolidated comprehensive information in a lucid way.
Manuscript should be type written in MS Word, Times New Roman having font size 12 in double space on A4 size paper with 1.5 inch margin on all the sides. Manuscript has to be submitted along with filled in Copyright Agreement Form duly signed by authors. The manuscript has to be sent to email@example.com
All manuscripts are subjected to peer review and are of high quality will be published.
A confirmation about the acceptance of manuscript will be informed through e-mail to the corresponding author. After confirmation, corresponding author have to pay Rs. 3500-00 (Three Thousand Five Hundred Rupees only) for Indian authors, USD 100 (Hundred US dollars only) for Foreign authors as Article Processing Charges.
The payment shall be remitted through proper channel mentioned in the e-mail communication. Please send the proof of payment to firstname.lastname@example.org
Manuscript has to be prepared in the specified format: Title page, Name of the author(s), Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion and References.
This page should consist of the appropriate title, names and addresses of authors along with contact details (complete postal address, e-mail and telephone number) of the corresponding author.
Abstract should contain not more than 200 words. The abstract should be concise and informative.
A maximum of 5 key words must be given immediately below the abstract.
This component should consist of the rationale of the investigation making use of necessary literature.
It is obvious to elaborate the experimental protocols that were employed in the study / investigation in this section. The information furnished should be clear and unambiguous.
As far as possible the results have to be given in the form of tables and or figures / graphs with relevant explanation where necessary.
This part needs executive summary of the study in accordance with results.
PHARMANEST Journal follows Vancouver Reference Style. The format of the references should be as follows;
Veronesi U, Maisonneuve P, Decensi A. Tamoxifen: An enduring star. J Natl Cancer Inst. 2007 Feb 21;99(4):258–60.
Butany J, Carmichael K, Leong SW, Collins MJ. Coronary artery stents: identification and evaluation. J Clin Pathol. 2005 Aug;58(8):795–804. Table 3, Common stent complications; p. 796.
Belitz HD, Grosch W, Schieberle P. Food chemistry. 3rd rev. ed. Burghagen MM, translator. Berlin: Springer, 2004, 1070 p.
Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. Chapter 29, Endometriosis; p. 1103–33.
Dontrovsky JO, Carr DB, Koltzenburg M, editors. Proceedings of the 10th World Congress on Pain; 2002 Aug 17–22; San Diego, CA. Seattle: IASP Press; c2003. 937 p.
Kempner JL. Aching heads, making medicine: gender and legitimacy in headache [dissertation]. [Philadelphia]: University of Pennsylvania; 2004. 271 p.
AMA: helping doctors help patients [Internet]. Chicago: American Medical Association; c1995– 2007. AMA launches exclusive partnership with the ReachMD Channel for medical professionals; 2007 Mar 26 [cited 2007 Mar 28]; [about 2 screens]. Available from: http://www.ama-assn.org/ama/ pub/category/17469.html
In case of the experiments on human/animals, author(s) should mention whether the procedure was followed in accordance with the ethical standards of the committee.
PHARMANEST is available ONLINE with ISSN Number 2231 - 0541. The contents of this Journal will encompass Peer Reviewed Articles, Short Communications besides the Original Research Articles of ambitious standards drawn from Pharmaceutical Sciences, Chemical Sciences, Biotechnology, Nanotechnology and allied healthcare sectors. The Journal maintains the standards of quality publication quite evident from the citations of the articles published with PHARMANEST Journal and also its Indexing in Research and Academic Databases.